D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
International Flavors & Fragrances
IFF
$16.5B
| $359K | ﹤0.01% |
+2,474
| New | +$359K |
|
2202
Parker-Hannifin
PH
$96.9B
| $357K | ﹤0.01% |
2,100
-1,700
| -45% | -$289K |
|
|
MLNT
2203
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $357K | ﹤0.01% |
+53,672
| New | +$357K |
|
2204
City Holding Co
CHCO
$1.83B
| $356K | ﹤0.01% |
4,662
-778
| -14% | -$59.4K |
|
2205
Sturm, Ruger & Co
RGR
$587M
| $355K | ﹤0.01% |
6,514
-9,460
| -59% | -$516K |
|
2206
BWX Technologies
BWXT
$15.2B
| $354K | ﹤0.01% |
6,788
-12,812
| -65% | -$668K |
|
2207
Kiniksa Pharmaceuticals
KNSA
$2.68B
| $354K | ﹤0.01% |
26,134
-69,122
| -73% | -$936K |
|
2208
Globe Life
GL
$11.3B
| $353K | ﹤0.01% |
3,951
-1,763
| -31% | -$158K |
|
|
PTE
2209
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $353K | ﹤0.01% |
+2,478
| New | +$353K |
|
2210
Deutsche Bank
DB
$69.7B
| $347K | ﹤0.01% |
45,513
-72,187
| -61% | -$550K |
|
|
BRSL
2211
Brightstar Lottery PLC
BRSL
$3.13B
| $347K | ﹤0.01% |
26,742
+1,284
| +5% | +$16.7K |
|
|
STKL
2212
SunOpta
STKL
$735M
| $347K | ﹤0.01% |
105,529
-58,528
| -36% | -$192K |
|
|
FRTA
2213
DELISTED
Forterra, Inc
FRTA
| $346K | ﹤0.01% |
+69,526
| New | +$346K |
|
2214
Ennis
EBF
$463M
| $345K | ﹤0.01% |
16,812
-15,455
| -48% | -$317K |
|
|
RDUS
2215
DELISTED
Radius Recycling
RDUS
| $345K | ﹤0.01% |
13,188
+3,925
| +42% | +$103K |
|
2216
Spyre Therapeutics
SYRE
$977M
| $345K | ﹤0.01% |
2,015
+1,259
| +167% | +$216K |
|
|
MZTI
2217
The Marzetti Company Common Stock
MZTI
$4.97B
| $344K | ﹤0.01% |
2,316
-4,697
| -67% | -$698K |
|
2218
Aqua Metals
AQMS
$5.27M
| $343K | ﹤0.01% |
1,026
-1,028
| -50% | -$344K |
|
|
LTC
2219
LTC Properties
LTC
$1.68B
| $342K | ﹤0.01% |
7,491
-7,930
| -51% | -$362K |
|
2220
B. Riley Financial
RILY
$176M
| $340K | ﹤0.01% |
16,318
-8,784
| -35% | -$183K |
|
2221
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $339K | ﹤0.01% |
12,206
-1,675
| -12% | -$46.5K |
|
2222
Rayonier
RYN
$4.04B
| $338K | ﹤0.01% |
11,714
-44,454
| -79% | -$1.28M |
|
2223
NexGen Energy
NXE
$4.56B
| $337K | ﹤0.01% |
216,100
-532,100
| -71% | -$830K |
|
2224
Diana Shipping
DSX
$214M
| $336K | ﹤0.01% |
145,035
+87,643
| +153% | +$203K |
|
|
SA
2225
Seabridge Gold
SA
$1.8B
| $335K | ﹤0.01% |
+24,730
| New | +$335K |
|